Sex Chromosome GWAS of Post-Traumatic Stress Disorder (PTSD)
创伤后应激障碍 (PTSD) 性染色体 GWAS
基本信息
- 批准号:10304019
- 负责人:
- 金额:$ 20.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-19 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAnxiety DisordersBiologicalBudgetsChromosomesCollaborationsDataData AggregationDevelopmentDiagnosisDiseaseEating DisordersEtiologyFamiliarityFemaleFutureGenderGenesGeneticGenetic RiskGenetic studyGenotypeHealthcareHeritabilityInternationalLengthLinkLiteratureMental DepressionMental disordersMeta-AnalysisMethodsMilitary PersonnelMolecular GeneticsPost-Traumatic Stress DisordersPrevalencePreventionPrevention strategyProceduresProtocols documentationPseudoautosomal RegionPsychiatryReportingResourcesRiskSamplingSex ChromosomesSex DifferencesSubstance Use DisorderTestingTimeTwin StudiesUnited StatesVariantWomanWorkX ChromosomeY Chromosomeautism spectrum disorderbasecostdisorder riskgenome wide association studygenomic datamalemennovelpsychiatric genomicspublic health relevancesexsubstance usesuccesstherapy developmenttreatment strategy
项目摘要
Project summary
The untreated burden of post-traumatic stress disorder (PTSD) in the United States is a massive contributor to
healthcare budgets in both the civilian and military sectors, and better treatment and prevention methods are
needed. One of the most powerful predictors of who will develop a particular psychiatric disorder – including
PTSD – is sex/gender. Women are diagnosed with post-traumatic stress disorder (PTSD), depression, eating
disorders, and certain anxiety disorders approximately two to three times as often as men. Conversely, males
are up to four times more likely to be diagnosed with autism and substance use disorders. In psychiatry, there
are few factors that reliably confer fold-change differences in risk, but sex differences are an exception.
Remarkably, the reasons for sex differences in prevalence of PTSD and other disorders remain relatively
unexplained. Large-scale genetic studies, such as genome-wide association studies (GWAS), have
demonstrated genetic effects on PTSD and other psychiatric disorders. However, a notable gap in the
literature is the omission of the X and Y chromosomes from nearly all major psychiatric GWAS. Here we
propose sex chromosome GWAS of large representative PTSD samples as a critical first step towards the
inclusion of sex chromosomes in all major psychiatric GWAS. Building upon our prior work leading analyses
for international groups, we will implement robust pipelines for sex chromosome analyses, which will expand
sex chromosome analysis to PTSD. This work will also provide the necessary analytic workflows and
collaboration building for future sex chromosome GWAS of all major psychiatric disorders. The field is almost
completely in the dark regarding sex-chromosome contributions to psychiatric disorders, and it is critical that
we identify sex chromosome loci and test for disproportionate contributions of sex chromosomes to genetic risk
for disorders like PTSD and depression, in order to discover novel clues about disease etiology. This work
may help to explain well-known sex differences in prevalence of psychiatric disorders, and sex chromosome
findings may prove critical for the development of treatment and preventative strategies for these debilitating
and costly disorders.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laramie Duncan其他文献
Laramie Duncan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laramie Duncan', 18)}}的其他基金
Sex Chromosome GWAS of Post-Traumatic Stress Disorder (PTSD)
创伤后应激障碍 (PTSD) 性染色体 GWAS
- 批准号:
10453583 - 财政年份:2021
- 资助金额:
$ 20.81万 - 项目类别:
Sex hormones and post-traumatic stress disorder (PTSD)
性激素和创伤后应激障碍(PTSD)
- 批准号:
10410486 - 财政年份:2020
- 资助金额:
$ 20.81万 - 项目类别:
Sex hormones and post-traumatic stress disorder (PTSD)
性激素和创伤后应激障碍(PTSD)
- 批准号:
10629383 - 财政年份:2020
- 资助金额:
$ 20.81万 - 项目类别:
Sex hormones and post-traumatic stress disorder (PTSD)
性激素和创伤后应激障碍(PTSD)
- 批准号:
10028212 - 财政年份:2020
- 资助金额:
$ 20.81万 - 项目类别:
Sex hormones and post-traumatic stress disorder (PTSD)
性激素和创伤后应激障碍(PTSD)
- 批准号:
10238943 - 财政年份:2020
- 资助金额:
$ 20.81万 - 项目类别:
Sex hormones and post-traumatic stress disorder (PTSD)
性激素和创伤后应激障碍(PTSD)
- 批准号:
10398466 - 财政年份:2020
- 资助金额:
$ 20.81万 - 项目类别:
相似海外基金
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
- 批准号:
10109165 - 财政年份:2024
- 资助金额:
$ 20.81万 - 项目类别:
Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
- 批准号:
10677075 - 财政年份:2023
- 资助金额:
$ 20.81万 - 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
- 批准号:
478121 - 财政年份:2023
- 资助金额:
$ 20.81万 - 项目类别:
Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
- 批准号:
10861961 - 财政年份:2023
- 资助金额:
$ 20.81万 - 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
- 批准号:
22KJ3164 - 财政年份:2023
- 资助金额:
$ 20.81万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
- 批准号:
10685283 - 财政年份:2022
- 资助金额:
$ 20.81万 - 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
- 批准号:
10042996 - 财政年份:2022
- 资助金额:
$ 20.81万 - 项目类别:
Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
- 批准号:
10705005 - 财政年份:2022
- 资助金额:
$ 20.81万 - 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
- 批准号:
10597521 - 财政年份:2022
- 资助金额:
$ 20.81万 - 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
- 批准号:
10573948 - 财政年份:2022
- 资助金额:
$ 20.81万 - 项目类别: